At @ year , the incidence of major adverse cardiac events ( death , nonfatal myocardial infarction , stroke , or repeat target vessel revascularization ) was significantly higher in the titanium group than in the everolimus group ( total , @ % vs @ % ; P = @ ; noninsulin-dependent subgroup , @ % vs @ % ; P = @ ; insulin-dependent subgroup , @ % vs @ % ; P = @ ) .